(Q37313183)

English

KP1019, a new redox-active anticancer agent--preclinical development and results of a clinical phase I study in tumor patients

scientific article published on October 2008

Statements

KP1019, a new redox-active anticancer agent--preclinical development and results of a clinical phase I study in tumor patients (English)
1 October 2008
2140-2155

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit